Skip To Main Content
Yin Ren on Muck Rack

Yin Ren

As seen in: Nature, Wiley Online Library, MDPI, Science Magazine, Royal Society of Chemistry
Is this you? As a journalist, you can create a free Muck Rack account to customize your profile, list your contact preferences, and upload a portfolio of your best work. Claim your profile

Get in touch with Yin

Contact Yin, search articles and posts on X, monitor coverage, and track replies from one place.

Learn more about Muck Rack

Actions

Share this page

Is this you?

As a journalist, you can create a free Muck Rack account to customize your profile, list your contact preferences, and upload a portfolio of your best work.
Claim your profile

Articles

Semitransparent PbS/BiFeO 3 Composite Photovoltaics With Selective UV–NIR Absorption Enabled by Size-Modulated Quantum Dots

|
By Luming Zhou, Junying Yu, Yin Ren
| Wiley Online Library Verified
LumingZhou, JunyingYu, YinRen, PengYe, LinHe, YahongWang, SisiLi, YingruiChen, RongliGao, ChunlinFu, Semitransparent PbS/BiFeO3 Composite Photovoltaics With Selective UV–NIR Absorption Enabled by Size-Modulated Quantum Dots, Advanced Engineering Materials2026, 0, e71007. https://doi.org/10.1002/adem.71007 Conflicts of Interest The authors declare no conflicts of interest. Data Availability Statement Data will be made available on request.
Open in Who Shared Issue with article?

Reply to “Comments on chemoradiotherapy in IDH wild-type/TERT-mutant grade 2/3 gliomas”

|
By jing jia zhang, Peng Wang MD, Yin Ren MD, Peng Wang, Yin Ren, LI YI CHEN, Jin Feng, Kaiwen Deng, Zhaoshi Bao, Xiaoguang Qiu, Yanwei Liu
| Wiley Online Library Verified
Zhang, J., Wang, P., Ren, Y., Chen, L., Feng, J., Liu, F., Deng, K., Bao, Z., Qiu, X. and Liu, Y. (2026), Reply to “Comments on chemoradiotherapy in IDH wild-type/TERT-mutant grade 2/3 gliomas”. Cancer, 132: e70359. https://doi.org/10.1002/cncr.70359 No abstract is available for this article. REFERENCES 1, , , et al. Chemoradiotherapy with temozolomide vs.
Open in Who Shared View Duplicates (2) Issue with article?

Chemoradiotherapy with temozolomide vs. radiotherapy alone in patients with IDH wild‐type and TERT promoter mutation histological grade 2/3 gliomas: An extension retrospective analysis of a randomized controlled trial

|
By jing jia zhang, Peng Wang, Yin Ren, LI YI CHEN
| Wiley Online Library Verified
INTRODUCTION In 2021, the World Health Organization (WHO) introduced a revised version of the molecular pathological grading system for gliomas (WHO CNS 5).1 A subgroup of IDH-wildtype (wt) diffuse astrocytomas diagnosed histologically as grade 2 to 3, yet possessing molecular features of either telomerase reverse transcriptase promoter mutation (TERTp-mut), and/or the combined pattern of whole chromosome 7 gain and whole chromosome 10 loss (+7/–10), and/or amplification of epidermal growth...
Open in Who Shared Issue with article?
See all 10 licensed articles (11 Total)